172 related articles for article (PubMed ID: 22139588)
1. Analysis of 43 cases of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus registered in the JLSG-96 and JLSG-02 studies in Japan.
Shioda Y; Adachi S; Imashuku S; Kudo K; Imamura T; Morimoto A
Int J Hematol; 2011 Dec; 94(6):545-51. PubMed ID: 22139588
[TBL] [Abstract][Full Text] [Related]
2. Central diabetes insipidus in pediatric patients with Langerhans cell histiocytosis: Results from the JLSG-96/02 studies.
Sakamoto K; Morimoto A; Shioda Y; Imamura T; Imashuku S;
Pediatr Blood Cancer; 2019 Jan; 66(1):e27454. PubMed ID: 30207064
[TBL] [Abstract][Full Text] [Related]
3. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
[TBL] [Abstract][Full Text] [Related]
4. Central diabetes insipidus as the inaugural manifestation of Langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents.
Marchand I; Barkaoui MA; Garel C; Polak M; Donadieu J;
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1352-60. PubMed ID: 21752883
[TBL] [Abstract][Full Text] [Related]
5. Central diabetes insipidus as a very late relapse limited to the pituitary stalk in Langerhans cell histiocytosis.
Nakagawa S; Shinkoda Y; Hazeki D; Imamura M; Okamoto Y; Kawakami K; Kawano Y
J Pediatr Endocrinol Metab; 2016 Jul; 29(7):873-8. PubMed ID: 27089406
[TBL] [Abstract][Full Text] [Related]
6. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis.
Prosch H; Grois N; Prayer D; Waldhauser F; Steiner M; Minkov M; Gadner H
Pediatr Blood Cancer; 2004 Oct; 43(5):594-9. PubMed ID: 15382278
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the etiological and clinical characteristics of pediatric central diabetes insipidus.
Gasimova E; Berberoğlu M; Özsu E; Aycan Z; Uyanık R; Bilici E; Ceran A; Şiklar Z
J Pediatr Endocrinol Metab; 2022 Aug; 35(8):1089-1096. PubMed ID: 35822703
[TBL] [Abstract][Full Text] [Related]
8. Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System.
Vaiani E; Felizzia G; Lubieniecki F; Braier J; Belgorosky A
Horm Res Paediatr; 2021; 94(1-2):9-17. PubMed ID: 34167121
[TBL] [Abstract][Full Text] [Related]
9. Central diabetes insipidus: beware of Langerhans cell histiocytosis!
Brys ADH; Vermeersch S; Forsyth R; Velkeniers B; Bravenboer B
Neth J Med; 2018 Dec; 76(10):445-449. PubMed ID: 30569891
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of central diabetes insipidus in Taiwanese children.
Liu SY; Tung YC; Lee CT; Liu HM; Peng SF; Wu MZ; Kuo MF; Tsai WY
J Formos Med Assoc; 2013 Oct; 112(10):616-20. PubMed ID: 23916565
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Central Diabetes Insipidus: Brain Malformations Are Common and Few Patients Have Idiopathic Disease.
Werny D; Elfers C; Perez FA; Pihoker C; Roth CL
J Clin Endocrinol Metab; 2015 Aug; 100(8):3074-80. PubMed ID: 26030323
[TBL] [Abstract][Full Text] [Related]
12. Central diabetes insipidus: Is it Langerhans cell histiocytosis of the pituitary stalk? A diagnostic pitfall.
Prosch H; Grois N; Bökkerink J; Prayer D; Leuschner I; Minkov M; Gadner H
Pediatr Blood Cancer; 2006 Mar; 46(3):363-6. PubMed ID: 15942956
[TBL] [Abstract][Full Text] [Related]
13. Central diabetes insipidus in children: Diagnosis and management.
Patti G; Ibba A; Morana G; Napoli F; Fava D; di Iorgi N; Maghnie M
Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101440. PubMed ID: 32646670
[TBL] [Abstract][Full Text] [Related]
14. Isolated Langerhans cell histiocytosis in the hypothalamic-pituitary region: a case report.
Zhou W; Rao J; Li C
BMC Endocr Disord; 2019 Dec; 19(1):143. PubMed ID: 31856773
[TBL] [Abstract][Full Text] [Related]
15. Endocrine features of Langerhans cell histiocytosis in paediatric patients: A 30-year review.
Alexander A; Zacharin M
J Paediatr Child Health; 2024 Jan; 60(1):24-27. PubMed ID: 38031464
[TBL] [Abstract][Full Text] [Related]
16. Predictor Variables of Developing Anterior Pituitary Deficiencies in a Group of Paediatric Patients with Central Diabetes Insipidus and Langerhans Cell Histiocytosis.
Vaiani E; Malossetti C; Vega LM; Zubizarreta P; Braier J; Belgorosky A
Horm Res Paediatr; 2017; 87(1):51-57. PubMed ID: 27951529
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of children with multiple system Langerhans cell histiocytosis by Japan Langerhans Cell Histiocytosis Study Group Protocol].
Huang JB; Xue HM; Chen YY; Huang K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):146-9. PubMed ID: 23484709
[TBL] [Abstract][Full Text] [Related]
18. Radiological evaluation of patients with pituitary langerhans cell histiocytosis at diagnosis and at follow-up.
Varan A; Cila A; Akyüz C; Kale G; Kutluk T; Büyükpamukçu M
Pediatr Hematol Oncol; 2008 Sep; 25(6):567-74. PubMed ID: 18728976
[TBL] [Abstract][Full Text] [Related]
19. [Thickening of the pituitary stalk in children and adolescents with central diabetes insipidus: Causes and consequences].
Corredor Andrés B; Muñoz Calvo MT; López Pino MÁ; Márquez Rivera M; Travieso Suárez L; Pozo Román J; Argente J
An Pediatr (Engl Ed); 2019 May; 90(5):293-300. PubMed ID: 29895434
[TBL] [Abstract][Full Text] [Related]
20. [Outcome Comparison of Pediatric Langerhans Cell Histiocytosis Treated with Modified DAL-HX83/90 or JLSG-96 Protocol].
Huang JB; Jiang L; Chen C; Xue HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1190-5. PubMed ID: 27531798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
